Cargando…

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study

BACKGROUND: Vaccine impact and cost-effectiveness models have mostly focused on acute burden. Shigella-attributable moderate-to-severe diarrhoea has been shown to be associated with childhood linear growth faltering. Evidence also links less severe diarrhoea to linear growth faltering. As Shigella v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, John D, Bagamian, Karoun H, Pecenka, Clint J, Muhib, Farzana, Puett, Chloe A, Hausdorff, William P, Scheele, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206199/ https://www.ncbi.nlm.nih.gov/pubmed/37202023 http://dx.doi.org/10.1016/S2214-109X(23)00192-4

Ejemplares similares

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study
por: Puett, Chloe, et al.
Publicado: (2023)

Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
por: Anderson, John D., et al.
Publicado: (2019)

Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
por: Anderson, John D, et al.
Publicado: (2019)

Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
por: Bagamian, Karoun H., et al.
Publicado: (2022)

Shigella and childhood stunting: Evidence, gaps, and future research directions
por: Bagamian, Karoun H., et al.
Publicado: (2023)

Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
por: Bagamian, Karoun H, et al.
Publicado: (2019)

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
por: Giersing, Birgitte K, et al.
Publicado: (2023)

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
por: Baral, Ranju, et al.
Publicado: (2021)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria
por: Anderson, John D., et al.
Publicado: (2020)

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
por: Baral, Ranju, et al.
Publicado: (2020)

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
por: Mahmud, Sarwat, et al.
Publicado: (2023)

Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries
por: Debellut, Frédéric, et al.
Publicado: (2019)

Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries
por: Debellut, Frédéric, et al.
Publicado: (2018)

Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries
por: Anderson, John D., et al.
Publicado: (2019)

Measurement of benefits in economic evaluations of nutrition interventions in low‐ and middle‐income countries: A systematic review
por: Wun, Jolene, et al.
Publicado: (2022)

What Drives the Value of a Shigella Vaccine?
por: Hausdorff, William P., et al.
Publicado: (2022)

Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
por: Baral, Ranju, et al.
Publicado: (2020)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Younger age of stroke in low‐middle income countries is related to healthcare access and quality
por: Rahbar, Mohammad H., et al.
Publicado: (2022)

Tobacco Control Progress in Low and Middle Income Countries in Comparison to High Income Countries
por: Anderson, Carrie L., et al.
Publicado: (2016)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Risk-based Vaccines and the Need for Risk-based Subnational Vaccination Strategies for Introduction
por: Muhib, Farzana B, et al.
Publicado: (2020)

Management of neonatal jaundice in low-income and middle-income countries
por: Erdeve, Omer
Publicado: (2020)

Tackling antimicrobial resistance in low-income and middle-income countries
por: Pokharel, Sunil, et al.
Publicado: (2019)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020)

Continued nursing education in low-income and middle-income countries: a narrative synthesis
por: Azad, Amee, et al.
Publicado: (2020)

Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings
por: Fleming, Jessica A., et al.
Publicado: (2023)

Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature
por: Hughes, Nicole, et al.
Publicado: (2016)

Dementia in low- and middle-income countries
por: Graham, Nori
Publicado: (2006)

Cost-effectiveness of club-foot treatment in low-income and middle-income countries by the Ponseti method
por: Grimes, Caris E, et al.
Publicado: (2016)

Specialization in acute care surgery in low-income and middle-income countries
por: Yi, Sojung, et al.
Publicado: (2017)

Achieving affordable critical care in low-income and middle-income countries
por: Turner, Hugo C, et al.
Publicado: (2019)

Emergency care research ethics in low-income and middle-income countries
por: Millum, Joseph, et al.
Publicado: (2019)

Maximizing the potential of trauma registries in low-income and middle-income countries
por: Rosenkrantz, Leah, et al.
Publicado: (2020)

Controlling infectious disease outbreaks in low-income and middle-income countries
por: Caeiro, Juan Pablo, et al.
Publicado: (2018)

Strengthening medical specialisation policy in low-income and middle-income countries
por: Sriram, Veena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8058lbmu6dhfhuc5j3bkk9r5l5